Ying Huang
Stock Analyst at B of A Securities
(2.36)
# 2,469
Out of 4,869 analysts
39
Total ratings
50%
Success rate
9.09%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $555 → $567 | $440.87 | +28.61% | 14 | Mar 31, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $108.50 | -33.64% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $29.52 | +59.21% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $8.43 | +848.99% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $1.07 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $2.32 | +1,624.14% | 2 | Mar 8, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $3.20 | +3,499.37% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $0.70 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $127.04 | +187.31% | 1 | Oct 18, 2017 | |
| BOLD Boundless Bio | Maintains: Buy | $23 → $33 | $1.04 | +3,073.08% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $289.33 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Mar 31, 2025
Maintains: Buy
Price Target: $555 → $567
Current: $440.87
Upside: +28.61%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $108.50
Upside: -33.64%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $29.52
Upside: +59.21%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $8.43
Upside: +848.99%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $1.07
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $2.32
Upside: +1,624.14%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $3.20
Upside: +3,499.37%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.70
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $127.04
Upside: +187.31%
Boundless Bio
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $1.04
Upside: +3,073.08%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $289.33
Upside: -